Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT06929169
Cardiovascular Effects of SGLT2 Inhibitors in Hemodialysis Patients: A Phase 2 Randomized Study (SGLT2-HD)
Sponsor: Maximo Agustin Schiavone
Interventions
iSGLT2
Updated 1 time since 2025 Last updated: Apr 8, 2025 Started: May 31, 2025 Primary completion: Jul 31, 2026 Completion: Aug 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2 trial investigates Chronic Kidney Disease Requiring Hemodialysis and is currently actively recruiting participants. Maximo Agustin Schiavone leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Maximo Agustin Schiavone
Data source: Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
For direct contact, visit the study record on ClinicalTrials.gov .